Lifecare AS (OL:LIFE) — Market Cap & Net Worth
Market Cap & Net Worth: Lifecare AS (LIFE)
Lifecare AS (OL:LIFE) has a market capitalization of $12.68 Million (Nkr120.48 Million) as of September 26, 2026. Listed on the OL stock exchange, this Norway-based company holds position #26526 globally and #242 in its home market, demonstrating a 2.78% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Lifecare AS's stock price Nkr0.30 by its total outstanding shares 407710448 (407.71 Million). Also see how large is Lifecare AS's balance sheet for a full breakdown of the balance sheet.
Lifecare AS Market Cap History: 2018 to 2026
Lifecare AS's market capitalization history from 2018 to 2026. Data shows change from $1.21 Billion to $12.68 Million (-41.12% CAGR). Also see cash flow conversion of Lifecare AS for how efficiently the company converts equity into cash flow.
Lifecare AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Lifecare AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Lifecare AS (LIFE) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1248.78x
Lifecare AS's market cap is 1248.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.21 Billion | $3.49 Million | -$8.79 Million | 346.32x | N/A |
| 2019 | $1.56 Billion | $2.07 Million | -$6.56 Million | 752.23x | N/A |
| 2020 | $2.06 Billion | $1.67 Million | -$2.74 Million | 1229.40x | N/A |
| 2021 | $801.66 Million | $324.41K | -$15.88 Million | 2471.11x | N/A |
| 2022 | $848.81 Million | $16.71 Million | -$17.48 Million | 50.78x | N/A |
| 2023 | $2.10 Billion | $13.09 Million | -$35.26 Million | 160.72x | N/A |
| 2024 | $525.56 Million | $3.03 Million | -$71.76 Million | 173.40x | N/A |
| 2025 | $139.86 Million | $112.00K | -$119.51 Million | 1248.78x | N/A |
Competitor Companies of LIFE by Market Capitalization
Companies near Lifecare AS in the global market cap rankings as of September 26, 2026. Review tangible net worth ratio of Lifecare AS to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Lifecare AS by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #129 globally with a market cap of $175.75 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Stryker Corporation (NYSE:SYK): Ranked #242 globally with a market cap of $103.47 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #129 | Abbott Laboratories | NYSE:ABT | $175.75 Billion | $101.07 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $88.51 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #242 | Stryker Corporation | NYSE:SYK | $103.47 Billion | $269.75 |
Lifecare AS Historical Marketcap From 2018 to 2026
Between 2018 and today, Lifecare AS's market cap moved from $1.21 Billion to $ 12.68 Million, with a yearly change of -41.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr12.68 Million | -90.94% |
| 2025 | Nkr139.86 Million | -73.39% |
| 2024 | Nkr525.56 Million | -75.01% |
| 2023 | Nkr2.10 Billion | +147.78% |
| 2022 | Nkr848.81 Million | +5.88% |
| 2021 | Nkr801.66 Million | -61.01% |
| 2020 | Nkr2.06 Billion | +32.12% |
| 2019 | Nkr1.56 Billion | +28.91% |
| 2018 | Nkr1.21 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 25th, 2026 the market cap of Lifecare AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.68 Million USD |
| MoneyControl | $12.68 Million USD |
| MarketWatch | $12.68 Million USD |
| marketcap.company | $12.68 Million USD |
| Reuters | $12.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Lifecare AS
Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway and United Kingdom. The company develops Sencell, a 3D printed nano-sensor for monitoring glucose levels in patients with diabetes and for veterinary applications; as well as medical devices that remove subdermal implants. Lifeca… Read more